In this cohort of patients leaving in a Mediterranean area and with a relatively long disease evolution we did not find an association between YKL-40 and adiponectin levels and the presence of subclinical CAD evaluated by CACS and CIMT. The gene discussed is ADIPOQ; the disease is coronary artery disorder.